PHA Hosts Baltimore Walk for Hope to Raise Awareness Next Sunday
The Baltimore Walk for Hope is an upcoming event organized by the Pulmonary Hypertension Association (PHA) to raise awareness about pulmonary hypertension. The event will take place next Sunday, November 2nd at the Baltimore Zoo.
The event is designed to be a 1.1 mile family and friendly walk around the zoo, and will also feature lectures from health care professionals and speeches from PH patients, music, food, and games. The importance of exercise in the management of PH will be emphasized by Jazzercise instructors before and after the walk.
The registration for the walk opens at 7:30 at the Baltimore Zoo. After the opening remarks and warm-up, the walk will take place between 9:00 and 10:00 a.m., followed by a post-walk celebration. Adults are asked to contribute $35, and children between 3 and 12 years old $20.
“Pulmonary hypertension is a rare, underdiagnosed and often misdiagnosed disease. At this time there is no cure, but we believe through research and awareness a cure for PH is on the horizon. The Baltimore Walk for Hope is one of many events taking place in November to help raise awareness and funding for research to fight back against this devastating disease,” explains the association in its website, encouraging PH community members to engage in their local communities, share their story, participate in awareness month events, and participate in national events.
As the leading pulmonary hypertension organization in the country, the PHA hosts numerous events each year to help raise funds and increase awareness about the disease. The PHA’s mission is to fund research aimed at preventing and ultimately curing PH, which is a rare and debilitating disease characterized by high blood pressure in the pulmonary arteries and difficulties in blood flow through the lungs to pick up oxygen. With a 2.8-year survival rate for untreated patients, PH is a deadly disease with seriously unmet therapeutic needs. However, the PHA’s efforts, together with researchers and pharmaceutical companies, has led to several approved treatments for the management of the disease that help improve patient quality of life.
The organization has also recently launched a new campaign to raise attention about the disease, called PHAware, designed to reach not only the general public, but also news media, and potential donors, to expand its exposure, both nationally and internationally. One of the most important initiatives of the new campaign is the launch of PHAware.org, a website and social media hotspot to gather and promote all of the PHA’s outward facing messaging.